Advantages of multiplex proteomics in clinical immunology: the case of rheumatoid arthritis: novel IgXPLEX™: planar microarray diagnosis (Q39920872)

15 September 2017

title

Advantages of multiplex proteomics in clinical immunology: the case of rheumatoid arthritis: novel IgXPLEX™: planar microarray diagnosis (English)

1 reference

15 September 2017

1 reference

0 references

Peter Lea

1

1 reference

15 September 2017

Edward Keystone

2

1 reference

15 September 2017

Sasi Mudumba

3

1 reference

15 September 2017

Anthony Kahama

4

1 reference

15 September 2017

Shi-Fa Ding

5

1 reference

15 September 2017

Jennifer Hansen

6

1 reference

15 September 2017

Azar A Azad

7

1 reference

15 September 2017

Sihe Wang

8

1 reference

15 September 2017

Deborah Weber

9

1 reference

15 September 2017

publication date

1 August 2011

1 reference

Clinical Reviews in Allergy & Immunology

15 September 2017

published in

1 reference

15 September 2017

volume

41

1 reference

15 September 2017

issue

1

1 reference

15 September 2017

page(s)

20-35

1 reference

Proteomic toolbox for autoimmunity research

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Genomics and proteomics: Applications in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Protein biomarker discovery and validation: the long and uncertain path to clinical utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics Programs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

The proteome: anno Domini 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Rheumatology: a close encounter with proteomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

The human plasma proteome: a nonredundant list developed by combination of four separate sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Affinity-capture reagents for protein arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Reversed-phase high-performance liquid chromatographic prefractionation of immunodepleted human serum proteins to enhance mass spectrometry identification of lower-abundant proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Sputum biomarkers of inflammation in cystic fibrosis lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Protein and antibody microarray technology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Protein arrays: proteomics in multiplex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Multiplex approaches in protein microarray technology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Suppression of non-specific binding in serological Luminex assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Effects of preanalytical variables on peptide and protein measurements in human serum and plasma: implications for clinical proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Correcting common errors in identifying cancer-specific serum peptide signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Prognostic laboratory markers of joint damage in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Autoantibodies in rheumatoid arthritis and their clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Use and significance of anti-CCP autoantibodies in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Clinical performance characteristics of a laboratory test. A practical approach in the autoimmune laboratory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Parallel detection of autoantibodies with microarrays in rheumatoid diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Diagnostic performance and predictive value of rheumatoid factor, anti-citrullinated peptide antibodies, and the HLA shared epitope for diagnosis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Antigen microarray profiling of autoantibodies in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Appropriateness of autoantibody testing in clinical medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

The laboratory approach to the diagnosis of autoimmune diseases: is it time to change?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Protein microarrays: challenges and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

The roles of multiple proteomic platforms in a pipeline for new diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Immunoproteomics: From biomarker discovery to diagnostic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Combination testing for antibodies in the diagnosis of coeliac disease: comparison of multiplex immunoassay and ELISA methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Recent advances in diagnostic technologies for autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Measurement and quality control issues in multiplex protein assays: a case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Quality control and protein microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Clinical laboratory testing for the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Antiphospholipid antibodies: lessons from the bench

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Consensus guidelines on anti-beta 2 glycoprotein I testing and reporting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Pathogenic antiphospholipid antibody: an antigen-selected needle in a haystack

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Clinical evaluation of a microsphere bead-based flow cytometry assay for the simultaneous determination of anti-thyroid peroxidase and anti-thyroglobulin antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Autoantibody profiling of patients with autoimmune thyroid disease using a new multiplexed immunoassay method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Refining clinical diagnosis with likelihood ratios

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Performance of the BioPlex 2200 Autoimmune Vasculitis kit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Infectious serologies and autoantibodies in Wegener's granulomatosis and other vasculitides: novel associations disclosed using the Rad BioPlex 2200.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

The role of neutrophil apoptosis in juvenile-onset systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Regulation of autoimmune encephalomyelitis by toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Induction of anti-whole GAD65 reactivity in vivo results in disease suppression in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Deficiency of thrombospondin-1 reduces Th17 differentiation and attenuates experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

The weight of interleukin-6 in B cell-related autoimmune disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Impact of vitamin D receptor activity on experimental autoimmune prostatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Autoimmunity against carbonic anhydrase II affects retinal cell functions in autoimmune retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Behçet's disease--a contemporary review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Non-organ-specific autoantibodies in chronic hepatitis C patients: association with histological activity and fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Anti-topoisomerase I autoantibodies in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Female predominance and X chromosome defects in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

How to diagnose rheumatoid arthritis early: A prediction model for persistent (erosive) arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-009-8189-Z

Active bead-linked immunoassay on protein microarrays

21 January 2018

1 reference

12 December 2020

Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis

1 reference

12 December 2020

A comparative study of IgG second- and third-generation anti-cyclic citrullinated peptide (CCP) ELISAs and their combination with IgA third-generation CCP ELISA for the diagnosis of rheumatoid arthritis

1 reference

12 December 2020

1 reference

12 December 2020

Formation and stability of a suspended biomimetic lipid bilayer on silicon submicrometer-sized pores

1 reference

12 December 2020

Expanding assay dynamics: a combined competitive and direct assay system for the quantification of proteins in multiplexed immunoassays

1 reference

12 December 2020

New molecular assays for cancer diagnosis and targeted therapy.

1 reference

12 December 2020

Acute transverse myelitis: a practical reappraisal.

1 reference

12 December 2020

Otosclerosis: an autoimmune disease?

1 reference

12 December 2020

Computer-assisted pattern recognition of autoantibody results

1 reference

12 December 2020

Evaluation of multiplexed fluorescent microsphere immunoassay for detection of autoantibodies to nuclear antigens

1 reference

12 December 2020

Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis

1 reference

12 December 2020

Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis

1 reference

12 December 2020

Diagnostic impact of contemporary biomarker assays for rheumatoid arthritis

1 reference

12 December 2020

Comparison between the standard anticardiolipin antibody test and a new phospholipid test in patients with connective tissue diseases.

1 reference

12 December 2020

A new strategy for the early diagnosis of rheumatoid arthritis: a combined approach

1 reference

12 December 2020

Whither autoimmunity: the lessons of anti-CCP and B cell depletion

1 reference

12 December 2020

Clinical proteomics--on the long way from bench to bedside?

1 reference

12 December 2020

Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study

1 reference

12 December 2020

10.1007/S12016-009-8189-Z

Identifiers

DOI

1 reference

15 September 2017

1 reference